Welcome to our dedicated page for URSB BANCORP news (Ticker: URSB), a resource for investors and traders seeking the latest updates and insights on URSB BANCORP stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect URSB BANCORP's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of URSB BANCORP's position in the market.
URSB Bancorp (OTCQB: URSB) closed its initial public offering on March 26, 2026, completing a mutual‑to‑stock conversion and beginning OTCQB quotation on March 27, 2026.
The company sold 2,314,375 shares at $10.00 per share for gross proceeds of approximately $23.1 million, issued 2,334,375 shares outstanding, contributed 20,000 shares to a charitable foundation, and sold 186,750 shares to its ESOP.